MEDFORD, MA--(Marketwired - March 11, 2014) - Hepregen Corporation, a leader in the development of next generation HepatoPac™ and HepatoMune™ cell-based in vitro assay products, announced today the ...
Multi-donor HEPATOPAC ® cultures allow for an experimental design in which data is obtained concurrently from pooled human donors in a single experiment. This gives a highly efficient method for ...
Human HEPATOPAC ® cultures are generated from well-characterized donors. Plates can be adjusted to include a single donor, a pooled donor, or numerous donors in separate wells on the same plate. The ...
HepatoPac(R) B-CLEAR(R) Co-Labeled Proprietary Product for Human Liver Transporter Analysis Provides Pharmaceutical and Chemical Industry With Best-in-Class Performance Hepregen and Qualyst co-launch ...
MEDFORD, MA--(Marketwired - January 29, 2015) - Today, Hepregen Corporation, a leader in the development of next generation HepatoPac ® and HepatoMune™ cell-based in vitro assay products, announced ...
Hepregen Corporation has announced the commercial launch of the Company’s first HepatoPac™ kit designed specifically for use in evaluating metabolic turnover of chemicals in the human liver. The kit ...
DILI contributes to the high failure rate of drug candidates in clinical development; but frequently DILI risk is not evident until late in clinical trials. There remains a need for better preclinical ...
HEPATOPAC micropatterned hepatocyte cultures are optimized for drug safety, metabolism and efficacy research Westbury, NY – June 3, 2019 – BioIVT, a leading provider of research models and services ...
Qualyst Transporter Solutions, LLC (Qualyst) and Hepregen Corporation have announced, at the American Association of Pharmaceutical Scientists/International Transporter Consortium ("AAPC/ITC") Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results